Key features and details
- Rabbit polyclonal to Dengue Virus 1+2+3+4
- Suitable for: ICC/IF
- Isotype: IgG
Product nameAnti-Dengue Virus 1+2+3+4 antibody
See all Dengue Virus 1+2+3+4 primary antibodies
DescriptionRabbit polyclonal to Dengue Virus 1+2+3+4
Tested applicationsSuitable for: ICC/IFmore details
Species reactivityReacts with Dengue Virus Types 1, 2, 3 and 4.
Viral particles from C6/36 [mosquito cell line] amplified dengue type 2 virus.
- dengue type III infected BHK21 cells
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
Concentration information loading...
Purification notesAmmonium sulphate precipitated
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab26837 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
RelevanceDengue and dengue hemorrhagic fever (DHF) are caused by one of four closely related, but antigenically distinct, virus serotypes (DEN1, DEN2, DEN3, and DEN4), of the genus Flavivirus.
ab26837 has been referenced in 3 publications.
- Calderón A et al. Two Cases of Natural Infection of Dengue-2 Virus in Bats in the Colombian Caribbean. Trop Med Infect Dis 6:N/A (2021). PubMed: 33809400
- Madhvi A et al. A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound. Sci Rep 7:5816 (2017). PubMed: 28725041
- Mateo R et al. Inhibition of cellular autophagy deranges dengue virion maturation. J Virol 87:1312-21 (2013). PubMed: 23175363